Skip to main content
. Author manuscript; available in PMC: 2017 May 1.
Published in final edited form as: JAMA Neurol. 2016 May 1;73(5):535–541. doi: 10.1001/jamaneurol.2016.0031

Table 1.

Unadjusted Mortality Rates by AP Exposure

Antipsychotic No. Patients Died/Total (%) Total Person-years Mortality Rate per 100 Person-years (95% CI)
Intention-to-treat analysis
 Haloperidol 60/282 (21.3)   122.5 49.0 (37.4–63.0)
 Other typical AP 20/140 (14.3)     64.0 31.3 (19.1–48.3)
 Olanzapine 113/837 (13.5)   386.3 29.3 (24.1–35.2)
 Quetiapine fumarate 462/5270 (8.8) 2488.8 18.6 (16.9–20.3)
 Risperidone 164/1155 (14.2)   529.5 31.0 (26.4–36.1)
 Other atypical AP 13/193 (6.7)     91.3 14.2 (7.6–24.3)
Exposure-only analysis
 Haloperidol 35/282 (12.4)     68.7 50.9 (35.5–70.9)
 Other typical AP 8/140 (5.7)     32.5 24.6 (10.6–48.5)
 Olanzapine 54/837 (6.5)   240.1 22.5 (16.9–29.3)
 Quetiapine 268/5270 (5.1) 1754.2 15.3 (13.5–17.2)
 Risperidone 96/1155 (8.3)   340.8 28.2 (22.8–34.4)
 Other atypical AP 7/193 (3.6)     59.1 11.8 (4.8–24.4)

Abbreviation: AP, antipsychotic.